Transfusion of red blood cells to patients with sepsis

International Journal of Molecular Sciences

Volumn 18, Issue 9, 2017, Pages

  Chan, Yi Ling ^a   Han, Shih Tsung ^a   Li, Chih Huang ^a   Wu, Chin Chieh ^a   Chen, Kuan Fu ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Red blood cells; Sepsis; Transfusion

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ACTIVATED PROTEIN C; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ENDOTOXIN; HEMOGLOBIN; HYDROCORTISONE; LACTIC ACID; PYRUVIC ACID; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; OXYGEN;

BLOOD VISCOSITY; CATECHOLAMINE RELEASE; CELL RESPIRATION; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HUMAN; HYPERLACTATEMIA; HYPOXEMIA; INFLAMMATION; META ANALYSIS (TOPIC); MICROCIRCULATION; OXYGEN CONSUMPTION; OXYGEN SATURATION; OXYGEN TENSION; PACKED RED BLOOD CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; CLINICAL TRIAL (TOPIC); METABOLISM; PROCEDURES;

CLINICAL TRIALS AS TOPIC; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; OXYGEN; SEPSIS;

EID: 85029348738     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18091946     Document Type: Review

References (88)

1. Angus, D.C.; Linde-Zwirble, W.T.; Lidicker, J.; Clermont, G.; Carcillo, J.; Pinsky, M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29, 1303-1310.
2. Sepsis Fact Sheet, National Institute of General Medical Sciences. Available online: https://www.nigms.nih.gov/education/pages/factsheet_sepsis.aspx (accessed on 15 May 2017).
3. Parrillo, J.E.; Parker, M.M.; Natanson, C.; Suffredini, A.F.; Danner, R.L.; Cunnion, R.E.; Ognibene, F.P. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 1990, 113, 227-242.
4. Dellinger, R.P.; Carlet, J.M.; Masur, H.; Gerlach, H.; Calandra, T.; Cohen, J.; Gea-Banacloche, J.; Keh, D.; Marshall, J.C.; Parker, M.M. et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 2004, 32, 858-873.
5. Beutler, B.; Milsark, I.W.; Cerami, A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985, 229, 869-871.
6. Bone, R.C.; Sibbald, W.J.; Sprung, C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101, 1481-1483.
7. Cohen, J. The immunopathogenesis of sepsis. Nature 2002, 420, 885-891.
8. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783-801.
9. Mogensen, T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 2009, 22, 240-273.
10. Angus, D.C.; van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 2013, 369, 840-851.
11. Thiemermann, C. Nitric oxide and septic shock. Gen. Pharmacol. 1997, 29, 159-166.
12. Chelazzi, C.; Villa, G.; Mancinelli, P.; de Gaudio, A.R.; Adembri, C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit. Care 2015, 19, 26.
13. Ayala, A.; Lomas, J.L.; Grutkoski, P.S.; Chung, C.S. Pathological aspects of apoptosis in severe sepsis and shock? Int. J. Biochem. Cell Biol. 2002, 35, 7-15.
14. Beltrán, B.; Orsi, A.; Clementi, E.; Moncada, S. Oxidative stress and S-nitrosylation of proteins in cells. Br. J. Pharmacol. 2000, 129, 953-960.
15. Sprung, C.L.; Caralis, P.V.; Marcial, E.H.; Pierce, M.; Gelbard, M.A.; Long, W.M.; Duncan, R.C.; Tendler, M.D.; Karpf, M. The effects of high-dose corticosteroids in patients with septic shock. N. Engl. J. Med. 1984, 311, 1137-1143.
16. Abraham, E.; Anzueto, A.; Gutierrez, G.; Tessler, S.; San Pedro, G.; Wunderink, R.; Dal Nogare, A.; Nasraway, S.; Berman, S.; Cooney, R. et al. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 1998, 351, 929-933.
17. Bernard, G.R.; Vincent, J.L.; Laterre, P.F.; LaRosa, S.; Dhainaut, J.F.; Lopez-Rodriguez, A.; Steingrub, J.; Garber, G.; Helterbrand, J.; Ely, E.W. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 2001, 344, 699-709.
18. Annane, D.; Sébille, V.; Charpentier, C.; Bollaert, P.E.; François, B.; Korach, J.M.; Capellier, G.; Cohen, Y.; Azoulay, E.; Troché, G. et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288, 862-871.
19. Van den Berghe, G.; Wouters, P.; Weekers, F.; Verwaest, C.; Bruyninckx, F.; Schetz, M.; Vlasselaers, D.; Ferdinande, P.; Lauwers, P.; Bouillon, R. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 2001, 345, 1359-1367.
20. Rivers, E.P.; Nguyen, H.B.; Havstad, S.; Ressler, J.; Muzzin, A.; Knoblich, B.; Peterson, E.D.; Tomlanovich, M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 2001, 345, 1368-1377.
21. Surviving Sepsis Campaign. Available online: http://www.survivingsepsis.org (accessed on 29 May 2017).
22. Barcelona Declaration-Surviving Sepsis Campaign. Available online: http://www.survivingsepsis.org/SiteCollectionDocuments/About-Barcelona-Declaration.pdf (accessed on 9 July 2017).
23. Ranieri, V.M.; Thompson, B.T.; Barie, P.S.; Dhainaut, J.F.; Douglas, I.S.; Finfer, S.; Gårdlund, B.; Marshall, J.C.; Rhodes, A.; Artigas, A. et al. Drotrecogin alfa (activated) in adults with septic shock. N. Engl. J. Med. 2012, 366, 2055-2064.
24. Sprung, C.L.; Annane, D.; Keh, D.; Moreno, R.P.; Singer, M.; Freivogel, K.; Weiss, Y.G.; Benbenishty, J.; Kalenka, A.; Forst, H. et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 2008, 358, 111-124.
25. Finfer, S.; Chittock, D.R.; Su, S.Y.S.; Blair, D.; Foster, D.; Dhingra, V.; Bellomo, R.; Cook, D.; Dodek, P.; Henderson, W.R. et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009, 360, 1283-1297.
26. Yealy, D.M.; Kellum, J.A.; Huang, D.T.; Barnato, A.E.; Weissfeld, L.A.; Pike, F.; Terndrup, T.; Wang, H.E.; Hou, P.C.; LoVecchio, F. et al. A randomized trial of protocol-based care for early septic shock. N. Engl. J. Med. 2014, 370, 1683-1693.
27. Peake, S.L.; Delaney, A.; Bailey, M.; Bellomo, R.; Cameron, P.A.; Cooper, D.J.; Higgins, A.M.; Holdgate, A.; Howe, B.D.; Webb, S.A.R. et al. Goal-directed resuscitation for patients with early septic shock. N. Engl. J. Med. 2014, 371, 1496-1506.
28. Mouncey, P.R.; Osborn, T.M.; Power, G.S.; Harrison, D.A.; Sadique, M.Z.; Grieve, R.D.; Jahan, R.; Harvey, S.E.; Bell, D.; Bion, J.F. et al. Trial of early, goal-directed resuscitation for septic shock. N. Engl. J. Med. 2015, 372, 1301-1311.
29. Phua, J.; Ngerng, W.; See, K.; Tay, C.; Kiong, T.; Lim, H.; Chew, M.; Yip, H.; Tan, A.; Khalizah, H. et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit. Care 2013, 17, R202.
30. Dhainaut, J.F. Role of clinical evaluation committees in sepsis trials: From “valid cohort” assessment to subgroup analysis. Crit. Care 2009, 13, 124.
31. Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M.; Bellomo, R.; Bernard, G.R.; Chiche, J.D.; Coopersmith, C.M. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016, 315, 801-810.
32. Shankar-Hari, M.; Phillips, G.S.; Levy, M.L.; Seymour, C.W.; Liu, V.X.; Deutschman, C.S.; Angus, D.C.; Rubenfeld, G.D.; Singer, M. Sepsis definitions task force developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016, 315, 775-787.
33. Kandel, G.; Aberman, A. Mixed venous oxygen saturation. Arch. Intern. Med. 1983, 143, 1400-1402.
34. Harms, M.P. M.; van Lieshout, J.J.; Jenstrup, M.; Pott, F.; Secher, N.H. Postural effects on cardiac output and mixed venous oxygen saturation in humans. Exp. Physiol. 2003, 88, 611-616.
35. Marino, P.L. Oxygen and Carbon Dioxide Transport. In The ICU Book, 2nd ed.; Lippincott, Williams & Wilkins: Philadelphia, PA, USA, 1998; p. 28.
36. Hayes, M.A.; Timmins, A.C.; Yau, E.H.; Palazzo, M.; Watson, D.; Hinds, C.J. Oxygen transport patterns in patients with sepsis syndrome or septic shock: Influence of treatment and relationship to outcome. Crit. Care Med. 1997, 25, 926-936.
37. Shoemaker, W.C.; Appel, P.L.; Kram, H.B. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest 1992, 102, 208-215.
38. Yu, M.; Levy, M.M.; Smith, P.; Takiguchi, S.A.; Miyasaki, A.; Myers, S.A. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study. Crit. Care Med. 1993, 21, 830-838.
39. Hayes, M.A.; Timmins, A.C.; Yau, E.H.; Palazzo, M.; Hinds, C.J.; Watson, D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Engl. J. Med. 1994, 330, 1717-1722.
40. 2 Collaborative Group. N. Engl. J. Med. 1995, 333, 1025-1032.
41. Park, D.W.; Chun, B.C.; Kwon, S.S.; Yoon, Y.K.; Choi, W.S.; Sohn, J.W.; Peck, K.R.; Kim, Y.S.; Choi, Y.H.; Choi, J.Y. et al. Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock. Crit. Care Med. 2012, 40, 3140-3145.
42. Weiskopf, R.B.; Viele, M.K.; Feiner, J.; Kelley, S.; Lieberman, J.; Noorani, M.; Leung, J.M.; Fisher, D.M.; Murray, W.R.; Toy, P. et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998, 279, 217-221.
43. 2 supply in critically ill patients. J. Crit. Care 1986, 1, 45-53.
44. Hanique, G.; Dugernier, T.; Laterre, P.F.; Dougnac, A.; Roeseler, J.; Reynaert, M.S. Significance of pathologic oxygen supply dependency in critically ill patients: Comparison between measured and calculated methods. Intensive Care Med. 1994, 20, 12-18.
45. Mira, J.P.; Fabre, J.E.; Baigorri, F.; Coste, J.; Annat, G.; Artigas, A.; Nitenberg, G.; Dhainaut, J.F. Lack of oxygen supply dependency in patients with severe sepsis: A study of oxygen delivery increased by military antishock trouser and dobutamine. Chest 1994, 106, 1524-1531.
46. 2 Availability. In Clinical Trials for the Treatment of Sepsis; Update in Intensive Care and Emergency Medicine; Springer: Berlin/Heidelberg, Germany, 1995; Volume 19, pp 106-121.
47. Marik, P.E.; Varon, J. Early goal-directed therapy: On terminal life support? Am. J. Emerg. Med. 2010, 28, 243-245.
48. Ince, C.; Sinaasappel, M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit. Care Med. 1999, 27, 1369-1377.
49. Bennett-Guerrero, E.; Veldman, T.H.; Doctor, A.; Telen, M.J.; Ortel, T.L.; Reid, T.S.; Mulherin, M.A.; Zhu, H.; Buck, R.D.; Califf, R.M. et al. Evolution of adverse changes in stored RBCs. Proc. Natl. Acad. Sci. USA 2007, 104, 17063-17068.
50. Goyette, R.E.; Key, N.S.; Ely, E.W. Hematologic changes in sepsis and their therapeutic implications. Semin. Respir. Crit. Care Med. 2004, 25, 645-659.
51. Stan, A.; Zsigmond, E. The restoration in vivo of 2,3-diphosphoglycerate (2,3-DPG) in stored red cells, after transfusion. The levels of red cells 2,3-DPG. Rom. J. Intern. Med. 2009, 47, 173-177.
52. Kim, J.; Lee, H.; Shin, S. Advances in the measurement of red blood cell deformability: A brief review. J. Cell Biotechnol. 2015, 1, 63-79.
53. Moutzouri, A.G.; Skoutelis, A.T.; Gogos, C.A.; Missirlis, Y.F.; Athanassiou, G.M. Red blood cell deformability in patients with sepsis: A marker for prognosis and monitoring of severity. Clin. Hemorheol. Microcirc. 2007, 36, 291-299.
54. Hurd, T.C. Red blood cell deformability in human and experimental sepsis. Arch. Surg. 1988, 123, 217-220.
55. Serroukh, Y.; Djebara, S.; Lelubre, C.; Zouaoui Boudjeltia, K.; Biston, P.; Piagnerelli, M. Alterations of the erythrocyte membrane during sepsis. Crit. Care Res. Pract. 2012, 2012, 1-7.
56. Blasi, B.; D’Alessandro, A.; Ramundo, N.; Zolla, L. Red blood cell storage and cell morphology. Transfus. Med. 2012, 22, 90-96.
57. Kor, D.J.; van Buskirk, C.M.; Gajic, O. Red blood cell storage lesion. Bosn. J. Basic. Med. Sci. 2009, 9, 21-27.
58. Riccio, D.A.; Zhu, H.; Foster, M.W.; Huang, B.; Hofmann, C.L.; Palmer, G.M.; McMahon, T.J. Renitrosylation of banked human red blood cells improves deformability and reduces adhesivity. Transfusion 2015, 55, 2452-2463.
59. D’Alessandro, A.; Kriebardis, A.G.; Rinalducci, S.; Antonelou, M.H.; Hansen, K.C.; Papassideri, I.S.; Zolla, L. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 2014, 55, 205-219.
60. Raat, N.J.H.; Ince, C. Oxygenating the microcirculation: The perspective from blood transfusion and blood storage. Vox Sang. 2007, 93, 12-18.
61. Marik, P.E. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993, 269, 3024-3029.
62. Walsh, T.S.; McArdle, F.; McLellan, S.A.; Maciver, C.; Maginnis, M.; Prescott, R.J.; McClelland, D.B. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit. Care Med. 2004, 32, 364-371.
63. Hsu, C.Y.; Liu, S.H.; Chao, C.H.; Chan, Y.L.; Tsai, T.C.; Chen, L.M.; Wu, C.C.; Chen, K.F. STROBE-compliant article: Blood transfusion within the first 24 h of hospitalization did not impact mortality among patients with severe sepsis. Medicine 2016, 95, e2601-e2607.
64. Sadaka, F.; Aggu-Sher, R.; Krause, K.; O’Brien, J.; Armbrecht, E.S.; Taylor, R.W. The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septic patients. Ann. Intensive Care 2011, 1, 46.
65. Kopterides, P.; Theodorakopoulou, M.; Nikitas, N.; Ilias, I.; Vassiliadi, D.A.; Orfanos, S.E.; Tsangaris, I.; Maniatis, N.A.; Tsantes, A.E.; Travlou, A. et al. Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis. Intensive Care Med. 2012, 38, 1843-1850.
66. Lacroix, J.; Hébert, P.C.; Fergusson, D.A.; Tinmouth, A.; Cook, D.J.; Marshall, J.C.; Clayton, L.; McIntyre, L.; Callum, J.; Turgeon, A.F. et al. Age of transfused blood in critically ill adults. N. Engl. J. Med. 2015, 372, 1410-1418.
67. Donati, A.; Damiani, E.; Luchetti, M.; Domizi, R.; Scorcella, C.; Carsetti, A.; Gabbanelli, V.; Carletti, P.; Bencivenga, R.; Vink, H. et al. Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: A pilot study. Crit. Care 2014, 18, R33.
68. Tsai, A.G.; Hofmann, A.; Cabrales, P.; Intaglietta, M. Perfusion vs. oxygen delivery in transfusion with “fresh” and ‘old’ red blood cells: The experimental evidence. Transfus. Apher. Sci. 2010, 43, 69-78.
69. Cabrales, P.; Tsai, A.G.; Intaglietta, M. Hemorrhagic shock resuscitation with carbon monoxide saturated blood. Resuscitation 2007, 72, 306-318.
70. Salazar Vázquez, B.Y.; Cabrales, P.; Tsai, A.G.; Johnson, P.C.; Intaglietta, M. Lowering of blood pressure by increasing hematocrit with non-nitric oxide-scavenging red blood cells. Am. J. Respir. Cell Mol. Biol. 2008, 38, 135-142.
71. Zimmerman, R.; Tsai, A.G.; Salazar Vázquez, B.Y.; Cabrales, P.; Hofmann, A.; Meier, J.; Shander, A.; Spahn, D.R.; Friedman, J.M.; Tartakovsky, D.M. et al. Posttransfusion increase of hematocrit per se does not improve circulatory oxygen delivery due to increased blood viscosity. Anesth. Analg. 2017, 124, 1547-1554.
72. Tsai, A.G.; Vázquez, B.Y. S.; Hofmann, A.; Acharya, S.A.; Intaglietta, M. Supra-plasma expanders. J. Infus. Nurs. 2015, 38, 217-222.
73. Holst, L.B.; Haase, N.; Wetterslev, J.; Wernerman, J.; Guttormsen, A.B.; Karlsson, S.; Johansson, P.I.; Åneman, A.; Vang, M.L.; Winding, R. et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N. Engl. J. Med. 2014, 371, 1381-1391.
74. Dupuis, C.; Sonneville, R.; Adrie, C.; Gros, A.; Darmon, M.; Bouadma, L.; Timsit, J.F. Impact of transfusion on patients with sepsis admitted in intensive care unit: A systematic review and meta-analysis. Ann. Intensive Care 2016, 1-13.
75. Brealey, D.; Brand, M.; Hargreaves, I.; Heales, S.; Land, J.; Smolenski, R.; Davies, N.A.; Cooper, C.E.; Singer, M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360, 219-223.
76. Singer, M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 2014, 5, 66-72.
77. Textoris, J.; Fouché, L.; Wiramus, S.; Antonini, F.; Tho, S.; Martin, C.; Leone, M. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit. Care 2011, 15, R176.
78. Dyson, A.; Stidwill, R.P.; Taylor, V.; Singer, M. Tissue oxygen monitoring in rodent models of shock. Am. J. Physiol. 2007, 293, H526-H533.
79. Arulkumaran, N.; Deutschman, C.S.; Pinsky, M.R.; Zuckerbraun, B.; Schumacker, P.T.; Gomez, H.; Gomez, A.; Murray, P.; Kellum, J.A.; ADQI XIV Workgroup. Mitochondrial function in sepsis. Shock 2016, 45, 271-281.
80. James, J.H.; Fang, C.H.; Schrantz, S.J.; Hasselgren, P.O.; Paul, R.J.; Fischer, J.E. Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle. Implications for increased muscle lactate production in sepsis. J. Clin. Investig. 1996, 98, 2388-2397.
81. Levy, B.; Gibot, S.; Franck, P.; Cravoisy, A.; Bollaert, P.-E. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: A prospective study. Lancet 2005, 365, 871-875.
82. Michaeli, B.; Martinez, A.; Revelly, J.P.; Cayeux, M.C.; Chioléro, R.L.; Tappy, L.; Berger, M.M. Effects of endotoxin on lactate metabolism in humans. Crit. Care 2012, 16, R139.
83. Sadaka, F. Red Blood Cell Transfusion in Sepsis: A Review. J. Blood Disord. Transfus. 2013, 4, 1-7.
84. Toy, P.; Gajic, O.; Bacchetti, P.; Looney, M.R.; Gropper, M.A.; Hubmayr, R.; Lowell, C.A.; Norris, P.J.; Murphy, E.L.; Weiskopf, R.B. et al. Transfusion-related acute lung injury: Incidence and risk factors. Blood 2012, 119, 1757-1767.
85. Goel, R.; Johnson, D.J.; Scott, A.V.; Tobian, A.A.R.; Ness, P.M.; Nagababu, E.; Frank, S.M. Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients. Transfusion 2016, 56, 1690-1698.
86. Hod, E.A.; Brittenham, G.M.; Billote, G.B.; Francis, R.O.; Ginzburg, Y.Z.; Hendrickson, J.E.; Jhang, J.; Schwartz, J.; Sharma, S.; Sheth, S. et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011, 118, 6675-6682.
87. Cross, J.H.; Bradbury, R.S.; Fulford, A.J.; Jallow, A.T.; Wegmüller, R.; Prentice, A.M.; Cerami, C. Oral iron acutely elevates bacterial growth in human serum. Sci. Rep. 2015, 5, 16670.
88. Rhodes, A.; Evans, L.E.; Alhazzani, W.; Levy, M.M.; Antonelli, M.; Ferrer, R.; Kumar, A.; Sevransky, J.E.; Sprung, C.L.; Nunnally, M.E. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit. Care Med. 2017, 45, 486-552.